Evaluation of coagulation kinetics using thromboelastometry-methodologic influence of activator and test medium

Sørensen, Benny; Fenger-Eriksen, Christian; Christiansen, Kirsten; Larsen, Ole H.; Ingerslev, Jørgen
November 2010
Annals of Hematology;Nov2010, Vol. 89 Issue 11, p1155
Academic Journal
Renewed interest has arisen in the use of thromboelastography/thromboelastometry in evaluating coagulation kinetics. The test medium, type of activator, and its concentration may influence the interpretation of coagulation kinetics. This study aimed to investigate methodologic influences of activator and test medium on thromboelastometric parameters of coagulation kinetics. Dynamic clot formation was evaluated by thromboelastometry using whole blood (WB), platelet-rich plasma, or platelet-poor plasma employing different concentrations of extrinsic (tissue factor) and contact activator (synthasil) and with variable concentrations of phospholipids. Plasma samples displayed prolonged clot initiation and enhanced clot propagation compared with WB. Clot firmness was markedly reduced in platelet-poor plasma as compared with platelet-rich plasma and WB. Increasing concentration of activator shortened the clot initiation and increased the velocity of clot propagation, whereas terminal clot firmness remained unaffected. Platelets accelerated clot propagation and raised clot firmness. Phospholipids shortened the time of clot initiation and increased velocity of propagation, while clot firmness remained unchanged. Our results demonstrate that evaluation of coagulation kinetics using thromboelastometry varies according to the composition of the test medium, type, and concentration of activator, as well as the presence and concentration of phospholipids in the test reagent.


Related Articles

  • Five-minute preparation of platelet-poor plasma for routine coagulation testing. Sultan, A. // Eastern Mediterranean Health Journal;feb2010, Vol. 16 Issue 2, p233 

    Clinical and Laboratory Standard Institute guidelines require that routine coagulation tests are performed with platelet-poor plasma (< 10 000 platelets/μL) and prepared from whole citrated blood centrifuged at low speed for 10-30 minutes. To compare results obtained from plasma centrifuged...

  • Neonatal platelet physiology and pathophysiology. Kühne, T.; Imbach, P. // European Journal of Pediatrics;1998, Vol. 157 Issue 2, p87 

    Abstract Platelets contribute to primary haemostatic events and are closely linked to plasmatic coagulation. Their function is highly dependent not only on their number but also on their integral physiology. In comparison with adults or children, the haemostasis of newborn infants, although...

  • Relation between coagulation/fibrinolysis and lactate in the course of human septic shock. Hartemink, Koen J.; Hack, C. Erik; Johan Groeneveld, A. B. // Journal of Clinical Pathology;Nov2010, Vol. 63 Issue 11, p12 

    Aim To study the relation between indicators of DIC and lactate concentrations over time to evaluate whether a coagulation/fibrinolysis imbalance could directly contribute to tissue hypoxygenation. Methods 14 consecutive septic shock patients with a pulmonary artery catheter in place were...

  • Platelets Retain High Levels of Active Plasminogen Activator Inhibitor 1. Brogren, Helén; Wallmark, Karin; Deinum, Johanna; Karlsson, Lena; Jern, Sverker // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    The vascular fibrinolytic system is crucial for spontaneous lysis of blood clots. Plasminogen activator inhibitor 1 (PAI-1), the principal inhibitor of the key fibrinolytic enzyme tissue-type plasminogen activator (tPA), is present in platelets at high concentrations. However, the majority of...

  • Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. Owens III, A. Phillip; Passam, Freda H.; Antoniak, Silvio; Marshall, Stephanie M.; McDaniel, Allison L.; Rudel, Lawrence; Williams, Julie C.; Hubbard, Brian K.; Dutton, Julie-Ann; Jianguo Wang; Tobias, Peter S.; Curtiss, Linda K.; Daugherty, Alan; Kirchhofer, Daniel; Luyendyk, James P.; Moriarty, Patrick M.; Nagarajan, Shanmugam; Furie, Barbara C.; Furie, Bruce; Johns, Douglas G. // Journal of Clinical Investigation;Feb2012, Vol. 122 Issue 2, p558 

    Hypercholesterolemia is a major risk factor for atherosclerosis. It also is associated with platelet hyperactivity, which increases morbidity and mortality from cardiovascular disease. However, the mechanisms by which hypercholesterolemia produces a procoagulant state remain undefined....

  • AGGREGATION AND ACTIVATION OF HUMAN BLOOD PLATELETS. Fantl, P.; Sweet, B. // Australian Journal of Experimental Biology & Medical Science;Apr1966, Vol. 44 Issue 2, p123 

    Examines the aggregation and activation of human blood platelets following the addition of adenosine-diphosphate and during the initial stages of the clotting process. Optical density of platelet-containing plasma; Behavior of plate-containing plasma from patients with von Willebrand's disease...

  • Understanding the Pathophysiology of Estrogen Clotting Issues: Oral vs Transdermal Routes. Nachtigall, Lila E. // Contemporary OB/GYN;Jan2009 Supplement, p12 

    The article discusses the pathophysiology of estrogen clotting issues. The cardiovascular risks associated with estrogen therapy is discussed. The effect of estrogen on arterial thrombosis is explained. Platelets and plasma coagulation factors are the two key contributors to clotting and thrombosis.

  • "Platelet-rich Plasma: Evidence to Support Its Use" Ley, John // Journal of Oral Implantology;2004, Vol. 30 Issue 4, p274 

    Deals with a study which presented the arguments for the use of platelet-rich plasma (PRP). Constituents of PRP; Cause of studies that suggest inferior results with PRP; Reason for the need for the PRP to be developed in an anticoagulated state.

  • CLOTTING IN HEPARINISED PLASMA II. UNDERLYING REACTIONS. Fantl, P. // Australian Journal of Experimental Biology & Medical Science;Feb1965, Vol. 43 Issue 1, p45 

    Examines the clotting time in heparinized plasma. Effect of adding thrombin; Difference in fibrin yield between platelet-containing and platelet-poor plasma; Presence of sodium chloride.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics